JPRN-UMIN000035805尚未招募未知
Proteomics analysis of cerebrospinal fluid for screening of POCD-associated molecules - Proteomics of cerebrospinal fluid
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Change of operation precedure from endvascular surgery to open surgery)
研究者
相似试验
已完成
不适用
Proteomics analysis of cerebrospinal fluid to investigate brain involvement in pre-eclampsianeurologische aandoeningen tijdens de zwangerschap10026908pre-eclampsiaNL-OMON43723Erasmus MC, Universitair Medisch Centrum Rotterdam40
招募中
不适用
Proteomics of cerebrospinal fluid after remote ischemic preconditioninganeurysm of the thoracic aortaJPRN-UMIN000034214Mie university hospital30
已完成
不适用
An investigation on spinal fluid in patients with sciatica-type or nerve-type pain of the lower limbeuropathic lower limb painNervous System DiseasesISRCTN34007592Trinity Translational Medicine Institute12
Unknown
不适用
Cerebrospinal Fluid Proteom in Dependence of Intranasal Breast MilkHydrocephalus in InfantsNCT04229693University Hospital of Cologne20
进行中（未招募）
不适用
Cerebrospinal fluid (CSF) and plasma pharmocokinetics of liposomal cytarabine (DepoCyte®) after intrathecal administration in children with malignant brain tumors and leptomeningeal disseminatioTo measure concentrations of liposomal cytarabine in CSF and plasma over time after intrathecal administration of liposomal cytarabine in children of different age groups with a malignant brain tumor and leptomenigeal dissemination. Measurements of concentrations of cytarabine after intrathecal administration of liposomal cytarabine will help to ensure proper dosage of liposomal cytarabine in small children, avoiding neurotoxic events and subtherapeutic drug levels.EUCTR2006-004982-32-ATMedical University of Vienna, Department of Pedatrics